Continuing Efficacy of Milnacipran Demonstrated After Long-Term Treatment of Fibromyalgia

Trial Profile

Continuing Efficacy of Milnacipran Demonstrated After Long-Term Treatment of Fibromyalgia

Completed
Phase of Trial: Phase IV

Latest Information Update: 27 Nov 2011

At a glance

  • Drugs Milnacipran (Primary)
  • Indications Fibromyalgia; Musculoskeletal pain
  • Focus Therapeutic Use
  • Most Recent Events

    • 27 Nov 2011 New trial record
    • 09 Nov 2011 Secondary analysis results presented at the 75th Annual Scientific Meeting of the American College of Rheumatology and the 46th Annual Meeting of the Association of Rheumatology and Health Professionals.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top